- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01856231
Lifestyle Physical Activity for People With COPD
September 22, 2017 updated by: Janet L. Larson, University of Michigan
The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training.
The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD.
The intervention includes a combination of (a) structured laboratory-based exercises with a behavioral intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home.
The subjects will be followed for a total of 18 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
People with chronic obstructive pulmonary disease (COPD) experience a gradual decline in physical activity (PA).
Exercise training in a structured pulmonary rehabilitation program can generate substantial gains in functional capacity, but increases in functional capacity do not necessarily lead to improvements in daily PA.
The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD.
The intervention includes a combination of (a) structured laboratory-based exercises with a self-efficacy enhancing intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home.
The intervention gradually transitions subjects from the structured laboratory-based exercises that focus on walking and circuit training to fully integrated lifestyle physical activities that integrate structured home-based exercises and lifestyle physical activities into daily life.
The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training and subjects will be followed for a total of 18 weeks.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan - School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 55 years or older
- Moderate to severe COPD (FEV1 < 80% and > 30% predicted; FEV1/FVC <70%) as the primary health problem
- Sedentary (less than 30 minutes of moderate activity 3 days/week)
Exclusion Criteria:
- No acute exacerbations or major illnesses requiring hospitalization in the last 8 weeks.
- No history of other major lung diseases as primary pulmonary problem, history of a recent heart attack or recent onset of chest pains with activity or increasing episodes of chest pain (unstable angina).
- No other health problems or mobility problems that limit physical activity.
- No child bearing potential
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 8 week group
Lifestyle physical activity self-efficacy
|
Subjects will come into an exercise lab 2 days per week and perform 10-20 minutes of walking, 13 strength training exercises, stretching and a behavioral intervention including goal setting, etc.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in physical activity measured by accelerometry
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Subjects wear two activity monitors for seven consecutive days (Actipal and Actigraph).
The study will compare the subject's activity level at the three time points listed.
|
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 6 minute walk test
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Subjects complete a 6 minute walk test measuring the total distance he/she can walk in 6 minutes at the three time points listed.
|
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
|
Change in lower extremity function (Short Physical Performance Battery)
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Subjects complete a performance test measuring balance, gait speed, and leg strength (using a chair stand test) at the three time points listed.
|
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
|
Change in dyspnea and fatigue (Pulmonary Functional Status and Dyspnea Questionnaire-Modified)
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Subjects complete a questionnaire answering questions about their level of dyspnea in various daily activities at the three time points listed.
|
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
|
Change in physical activity measured by CHAMPS questionnaire
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Subjects fill out a questionnaire of their perceived physical activity at the three time points listed.
|
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Janet Larson, PhD, University of Michigan - School of Nursing
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
May 9, 2013
First Submitted That Met QC Criteria
May 14, 2013
First Posted (Estimate)
May 17, 2013
Study Record Updates
Last Update Posted (Actual)
September 26, 2017
Last Update Submitted That Met QC Criteria
September 22, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HUM00038130
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Lifestyle physical activity - self-efficacy
-
Glasgow Caledonian UniversityUniversity of Edinburgh; Edinburgh Napier UniversityCompleted
-
University of Social Sciences and Humanities, WarsawUniversity of Zurich; Curtin University; Free University of BerlinCompletedAdolescent BehaviorPoland
-
Binghamton UniversityLehigh University; Ascension HealthRecruitingObesity | Physical Activity | Self-efficacy | Online Intervention | AccelerometersUnited States
-
Iowa State UniversityMichigan State UniversityNot yet recruitingObesity | Overweight
-
Jamie JacksonCompletedPhysical Activity | Cardiovascular Disease OtherUnited States
-
Jamie JacksonNational Heart, Lung, and Blood Institute (NHLBI)CompletedPhysical Activity | Cardiovascular Disease OtherUnited States
-
Nemours Children's ClinicCompletedObesity | Cardiovascular Disease
-
Northwestern UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Osteoarthritis, KneeUnited States
-
Centro de Investigacion SanitariaUniversity of Helsinki; International Diabetes FederationCompletedGlucose Metabolism Disorders | Type 2 DiabetesColombia
-
Xiao-dong ZhuangCompleted